- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Contact Webmaster
- Website policies
- Disability services
The study, published in the journal Hepatology, examined the clinical and economic outcomes of direct-acting antiviral therapy, which cures hepatitis C in nearly 95 percent of patients.
The Department of Pharmaceutical Outcomes & Policy is proud to announce that Yan Li was the winner of the 2019 poster competition in the category of “Pain, Addiction, and CNS […]
New study examining the effectiveness and safety of apixaban versus rivaroxaban is published in the Lancet Hematology
UF College of Pharmacy researchers led the study featuring approximately 15,000 patients.
The FDA awarded a $330,000 grant to Almut Winterstein, Ph.D., to lead the 18-month study.
Dawwas was awarded an American Association of University Women international fellowship in 2017-18.
Our Ph.D. graduates Fall 2018: Monica Munoz, Pharm.D., M.S., Ph.D.; Ghadeer Dawwas, BS.Pharm., M.B.A., Ph.D.; Abdullah Alalwan, Pharm.D., Ph.D.; and Ju Hyeun (Elise) Kim, Pharm.D., Ph.D.
They are pictured with advisors Abraham Hartzema, Pharm.D., MSPH, Ph.D., FISPE; Haesuk Park, Ph.D. and Almut Winterstein, RPh, Ph.D., FISPE